Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 +3.63%18 Gross Margin % is 51.71% as of Mar. 2026, which is 3% above its 10-year median of 50.28. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Aptus Pharma ranks better than 92.37% on this metric.
The historical rank and industry rank for Aptus Pharma's Gross Margin % or its related term are showing as below:
BOM:544529'
s Gross Margin % Range Over the Past 10 Years
Min: 42.24 Med: 50.28 Max: 63.2
Current: 54.12
During the past 4 years, the highestGross Margin % of Aptus Pharma was 63.20%. The lowest was 42.24%. And the median was 50.28%.
BOM:544529's Gross Margin % is ranked better than 92.37% of 118
companies
in the Medical Distribution industry
Industry Median: 14.9
vs BOM:544529: 54.12
Aptus Pharma had a gross margin of 51.71% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Aptus Pharma was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Aptus Pharma had a gross margin of 51.71% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Aptus Pharma Gross Margin % Related Terms
Aptus Pharma Gross Margin % Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544529 vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Aptus Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Aptus Pharma (BOM:544529) has a Gross Margin % of 51.71% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Aptus Pharma and its competitors. This is near median its historical median of 50.28. Over the past decade, Aptus Pharma's Gross Margin % has ranged from 42.24 to 63.20. According to the industry distribution chart, Aptus Pharma ranks #9 out of 118 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is Aptus Pharma's Gross Margin % too high?
Aptus Pharma's current Gross Margin % of 51.71% is near median its 10-year median of 50.28. Over the past 10 years, this metric has ranged from a low of 42.24 to a high of 63.20. The Medical Distribution industry median Gross Margin % is 14.90. Aptus Pharma's value of 51.71% is 247% above this industry median. Based on the distribution chart, Aptus Pharma ranks #9 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #9 out of 118 companies for Gross Margin %. This places Aptus Pharma in the top 8% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 14.90. Aptus Pharma's value of 51.71% is 247% above this benchmark. Historically, Aptus Pharma's own Gross Margin % has ranged from 42.24 to 63.20 over the past decade. While the company's 10-year median is 50.28 vs. the industry median of 14.90, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current Gross Margin % of 51.71% is 247% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current Gross Margin % is 51.71%, which is near median its own 10-year median of 50.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Gross Margin % of 51.71%. The current Gross Margin % is 51.71%, which is near median its 10-year median of 50.28 and 247% above the Medical Distribution industry median of 14.90. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Gross Margin % is 51.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
